Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
VTRS · Nasdaq · United States · Pharmaceutical Preparations
In shortViatris Inc is loss-making, generates cash and carries moderate debt, with revenue shrinking (−3.0% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -18.6% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -24.6% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -21.1% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -8.8% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.38× | 48/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.98× | 57/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 96.50× | 0/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -5.65× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 0.65 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 13.5% | 74/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 4 of 5 | 0/100 |
| Revenue growth volatility | 24.8% | 19/100 |
| Operating margin volatility | 10.8% | 11/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -4.2% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 17,886 | 16,263 | 15,427 | 14,739 | 14,300 |
| Cost of revenue | 12,311 | 9,766 | 8,988 | 9,116 | 9,286 |
| Gross profit | 5,576 | 6,497 | 6,439 | 5,624 | 5,014 |
| Research & development | 751 | 662 | 805 | 809 | 966 |
| Selling, general & admin | 4,529 | 4,179 | 4,070 | 4,105 | 3,794 |
| Operating income | (34) | 1,615 | 766 | 10 | (2,663) |
| Interest expense | 636 | 592 | 573 | 550 | 471 |
| Pre-tax income | (664) | 2,813 | 203 | (623) | (3,665) |
| Income tax | 605 | 735 | 148 | 11 | (150) |
| Net income | (1,269) | 2,079 | 55 | (634) | (3,515) |
| Diluted EPS | −$1.05 | $1.71 | $0.05 | −$0.53 | −$3.00 |
| Diluted shares (millions) | 1,209 | 1,217 | 1,207 | – | – |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Viatris Inc are included in the Investor plan. Try free for 7 days →
0.65 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026